Free tool
FAERS Monitor: Azactam
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050580 or its brand name (Azactam, Aztreonam). Reports on generic versions are filed under their own applications.
Reports
2,727
Serious
2,510
92% of reports
Hospitalization
1,413
Death reported
590
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use194
- pyrexia176
- eosinophilia160
- drug ineffective152
- dyspnoea134
- rash131
- acute kidney injury127
- drug reaction with eosinophilia and systemic symptoms120
- thrombocytopenia117
- septic shock103
- condition aggravated101
- renal failure98
- drug hypersensitivity94
- pneumonia91
- death88
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 42 |
| 2005 | 46 |
| 2006 | 51 |
| 2007 | 37 |
| 2008 | 47 |
| 2009 | 50 |
| 2010 | 50 |
| 2011 | 85 |
| 2012 | 78 |
| 2013 | 75 |
| 2014 | 124 |
| 2015 | 104 |
| 2016 | 148 |
| 2017 | 139 |
| 2018 | 158 |
| 2019 | 206 |
| 2020 | 207 |
| 2021 | 264 |
| 2022 | 161 |
| 2023 | 183 |
| 2024 | 215 |
| 2025 | 149 |
| 2026 | 108 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,432 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| eosinophiliaSignal | 160 | 71.1 | 61.1 | 10,892 |
| drug reaction with eosinophilia and systemic symptomsSignal | 120 | 36.1 | 30.3 | 4,050 |
| septic shockSignal | 103 | 18.3 | 15.1 | 1,667 |
| thrombocytopeniaSignal | 117 | 8.1 | 6.8 | 722 |
| acute kidney injurySignal | 127 | 6.4 | 5.4 | 578 |
| renal failureSignal | 98 | 5.7 | 4.7 | 377 |
| pyrexiaSignal | 176 | 3.9 | 3.4 | 387 |
| drug hypersensitivitySignal | 94 | 3.7 | 3.1 | 188 |
| condition aggravatedSignal | 101 | 2.6 | 2.1 | 96 |
| rashSignal | 131 | 2.3 | 2.0 | 99 |
| pneumoniaSignal | 91 | 2.2 | 1.8 | 57 |
| dyspnoea | 134 | 1.8 | 1.5 | 51 |
| off label use | 194 | 1.7 | 1.5 | 59 |
| drug ineffective | 152 | 0.9 | 0.8 | 2 |
| death | 88 | 0.8 | 0.6 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.